Bachem Holding AG
↗Bubendorf, Switzerland
Bachem is a leading, innovation-driven Swiss-based company specializing in the development and manufacture of peptides and oligonucleotides (TIDES). As a premier Contract Development and Manufacturing Organization (CDMO), Bachem supports pharmaceutical and biotechnology companies across the full lifecycle of drug development, from early research and clinical development to reliable large-scale commercial API (Active Pharmaceutical Ingredient) supply.
With over 50 years of experience, the company operates a global network of production facilities in Switzerland, the United States, and the United Kingdom. Bachem is recognized for its deep scientific expertise in complex molecular synthesis, purification, and quality control, enabling partners to translate complex molecules into viable, life-saving therapies.
CLASSIFICATION
Company Type:CDMO
Therapeutic Areas:
Industry:CDMO
Sub-Industry:Peptide and Oligonucleotide Manufacturing
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$695.1M (2025)
Founded:1971
Ownership:public
Status:operating
STOCK
Exchange:SIX Swiss Exchange
Ticker:BANB
Market Cap:$6.47B
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (Bachem is a CDMO, not a drug developer)
Modalities:Peptides, Oligonucleotides
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Ingro Finanz AG
Subsidiaries:Bachem AG, Bachem Americas, Inc., Bachem Sisslerfeld AG
Key Partnerships:GlyTech (glycosylated proteins and peptides)
COMPETITION
Position:Leader
Competitors:PolyPeptide Group, Lonza, Thermo Fisher Scientific (Patheon), WuXi AppTec
LEADERSHIP
Key Executives:
Anne-Kathrin Stoller - CEO
Hans van Hees - COO
Alain Schaffter - CFO
Board Members:Kuno Sommer (Chairman)
LINKS
Website:bachem.com
LinkedIn:LinkedIn Profile
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Bachem Holding AG and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Bachem Holding AG. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.